McPhee SW, Janson CG, Li C, Samulski RJ, Camp AS, Francis J, Shera D, Lioutermann L, Feely M, Freese A, Leone P. Immune responses to AAV in a phase I study for Canavan disease. J Gene Medicine, 8(5):577-88, 2006.

Janson C, McPhee S, Bilaniuk L, Haselgrove J, Testaiuti M, Freese A, Wang DJ, Shera D, Jurh P, Rupin J, Saslow E, Goldfarb O, Goldberg M, Larijani G, Sharrar W, Liouterman L, Camp A, Kolodny E, Samulski RJ, Leone P. 2002. Clinical protocol. Gene therapy of Canavan Disease: AAV-2 vector delivery of aspartylcyclase gene (ASPA) to the human brain. Human Gene Therapy, 13(11):1391-1412